SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. (Q47770712)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Escherichia coli

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Patrick C Y Woo

1

object named as

Patrick C Y Woo

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Susanna Kar-Pui Lau

2

object named as

Susanna K P Lau

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

3

object named as

Hoi-Wah Tsoi

1 reference

Europe PubMed Central

13 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

Beatrice H L Wong

5

object named as

Beatrice H L Wong

1 reference

Europe PubMed Central

13 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

author name string

Linqi Zhang

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Jim K H Chan

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Lei-Po Wong

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Wei He

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Chi Ma

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Kwok-Hung Chan

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

David D Ho

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

42

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

4959-4968

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike p

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

SARS antibody test for serosurveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Effects of a SARS-associated coronavirus vaccine in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

A single dose of oral DNA immunization delivered by attenuated Salmonella typhimurium down-regulates transgene expression in HBsAg transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

DNA immunization using a secreted cell wall antigen Mp1p is protective against Penicillium marneffei infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Approaches to enhance the efficacy of DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.05.023

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993989%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47770712&oldid=2113641396"